Cargando…
Mucociliary clearance augmenting drugs block SARS-CoV-2 replication in human airway epithelial cells
The coronavirus disease (COVID-19) pandemic, caused by SARS-CoV-2 coronavirus, is devastatingly impacting human health. A prominent component of COVID-19 is the infection and destruction of the ciliated respiratory cells, which perpetuates dissemination and disrupts protective mucociliary transport...
Autores principales: | Campos-Gómez, Javier, Fernandez Petty, Courtney, Mazur, Marina, Tang, Liping, Solomon, George M., Joseph, Reny, Li, Qian, Peabody Lever, Jacelyn E., Hussain, Shah Saddad, Harrod, Kevin S., Onuoha, Ezinwanne E., Kim, Harrison, Rowe, Steven M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Physiological Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042606/ https://www.ncbi.nlm.nih.gov/pubmed/36809189 http://dx.doi.org/10.1152/ajplung.00285.2022 |
Ejemplares similares
-
Mucociliary Clearance Augmenting Drugs Block SARS-Cov-2 Replication in Human Airway Epithelial Cells
por: Campos-Gomez, Javier, et al.
Publicado: (2023) -
Mucociliary Transport Deficiency and Disease Progression in Syrian Hamsters with SARS-CoV-2 Infection
por: Li, Qian, et al.
Publicado: (2022) -
Mucociliary transport deficiency and disease progression in Syrian hamsters with SARS-CoV-2 infection
por: Li, Qian, et al.
Publicado: (2023) -
Regional Differences in Mucociliary Clearance in the Upper and Lower Airways
por: Rogers, Troy D., et al.
Publicado: (2022) -
Airway Epithelial Nucleotide Release Contributes to Mucociliary Clearance
por: van Heusden, Catharina, et al.
Publicado: (2021)